Apollo Neuroscience, Inc. — Form D/A

Apollo Neuroscience, Inc. of PITTSBURGH, PA, a company, filed a Form D amendment with the SEC on 2023-10-12. The offering totals $10.0M, of which $6.0M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2023-10-12
• Form: D/A
• Accession: 0001735427-23-000003
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $10.0M
• Amount sold: $6.0M
• Remaining: $4.0M
• Investors: 10
• Date of first sale: 2023-02-09
• Revenue range: Decline to Disclose
• SEC file number: 021-474027

Issuer

• Name: Apollo Neuroscience, Inc.
• CIK: 0001735427
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 1942 FIFTH AVENUE, PITTSBURGH, PA, 15219
• Phone: (518) 312-0567

Officers, directors & promoters (9)

Other filings by this issuer (9)

More

• CIK 1735427 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search